This suggests that TNFα treatment can be used as a basic in vitro model for studying the pathophysiology of mitochondrial dysfunction and related metabolic complications and screening potential anti-obesity therapeutics in 3T3-L1 adipocytes. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.